Dr. Paul D. Aridgides, MD

Dr. Aridgides practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Aridgides' NPI, 1851537872, was assigned on December 22, 2008. Dr. Aridgides graduated from SUNY Upstate Medical University in 2008. Dr. Aridgides holds New York license 252570.

Dr. Aridgides' primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Aridgides' primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Aridgides is also affiliated with Guthrie Cortland Medical Center. The medical group on file is Guthrie Medical Group. Dmand AI also links Dr. Aridgides to 2 more medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aridgides practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Aridgides' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Aridgides is licensed in New York.

CMS data shows 275 Medicare services from Dr. Aridgides across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $12,544 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Aridgides in 2024. The largest group is 65 to 74, with 60 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aridgides' median patient age at 64, with 56% women.

In 2019, Dr. Aridgides wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $122 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

Dr. Aridgides accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aridgides as offering telehealth.

Dmand AI links 20 papers to Dr. Aridgides, published from 2010 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Central Nervous System Neoplasms. Dr. Aridgides has published most often in J Neurooncol. Dr. Aridgides' most frequent co-authors are Jeffrey A. Bogart, MD, Daniel J. Indelicato, MD and Ralph Philip Ermoian, MD.

Dmand AI links Dr. Aridgides to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Vaginal Neoplasms and Vaginal Diseases.

CMS Open Payments shows 3 general payments to Dr. Aridgides from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $29.

Dr. Aridgides graduated from SUNY Upstate Medical University in 2008.